Drug repurposing for rare diseases

Odiparcil for the use in MPS VI

Investigators: Hilde Stevens, Isabelle Huys

Impact of the COVID-19 pandemic for R&D on therapies for rare diseases

Investigators: Hilde Stevens, Sofia […]

2021-03-01T19:08:43+01:00March 1st, 2021|Research|
Load More Posts